期刊
RESPIRATORY MEDICINE
卷 103, 期 2, 页码 180-186出版社
W B SAUNDERS CO LTD
DOI: 10.1016/j.rmed.2008.11.012
关键词
Idiopathic pulmonary fibrosis; Echocardiography; Brain natriuretic peptide; Prognostic factor
Backgrounds: Pulmonary hypertension (PH) in idiopathic pulmonary fibrosis (IPF) is associated with poor prognosis. Recently echocardiography and brain natriuretic peptide (BNP) have been used as non-invasive markers for PH suggesting that they may also be used as markers for survival. The aim of this study was to evaluate the clinical usefulness of echocardiography and BNP by analyzing their association with survival. Methods: Retrospective review of 131 patients with IPF who underwent both echocardiography and BNP measurement at a tertiary referral center. Results: Mean follow-up period was 10.1 months. Using systolic pulmonary arterial pressure of 40 mmHg as a threshold for PH, patients with PH had poor survival (1-year mortality rate: 61.2%, mean survival: 10.8 months) than those without PH (19.9%, 23.7 months; p < 0.001). The prognosis of the subjects with increased BNP levels was poorer than those with normal BNP Levels (1-year mortality rate: 70.5% vs. 23.7%, mean survival: 11.0 months vs. 22.5 months; p < 0.001) and on multivariate analysis, only BNP Level was an independent predictor of prognosis. On serial evaluation, the survival of patients with newly developed PH and/or elevated BNP levels was similar to that of patients with PH at the initial measurement, suggesting that development of PH is indicative of poor prognosis regardless of the timing of the test. Conclusions: Although both BNP level and PH by echocardiography are clinically useful noninvasive and easily repeatable markers of prognosis, BNP level seems to be better. (C) 2008 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据